NCT05944627View on ClinicalTrials.gov

Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

February 28, 2026

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

FURESTEM-OA Kit Inj.

FURESTEM-OA Kit Inj. is a combination medical product in which FURESTEM-OA Inj. (solution 1) is the primary mode of action and CAM Inj. (solution 2) acts as an auxiliary. The product is administered after mixing solution 1 and solution 2.

BIOLOGICAL

Placebo

placebo administration in Phase 2a clinical trial

All Listed Sponsors
lead

Kang Stem Biotech Co., Ltd.

INDUSTRY

NCT05944627 - Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis | Biotech Hunter | Biotech Hunter